当前位置：
X-MOL 学术
›
Hepatology
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Erratum
Hepatology ( IF 13.5 ) Pub Date : 2022-08-30 , DOI: 10.1002/hep.32717
TABLE 1. Demographics of patients who underwent LT evaluation
中文翻译：
勘误表
表 1.接受 LT 评估的患者的人口统计资料
更新日期：2022-08-30
Hepatology ( IF 13.5 ) Pub Date : 2022-08-30 , DOI: 10.1002/hep.32717
In Musto, et al.,[1] for Table 1, the number values in the rows listed under PEAK Meld were formatted incorrectly as dates. The corrected Table 1 is shown here.
| Variable | Transplant | No transplant no recovery | Recovery | p-value |
|---|---|---|---|---|
| Mean age (SD) | 44.2 (11.5) | 50.0 (9.8) | 43.6 (10.8) | 0.004 |
| Male | 32/49 (65.3%) | 47/61 (77.0%) | 19/34 (55.9%) | 0.09 |
| BMI median (range) | 31.1 (22.7–53.5) | 30.5 (18.5–77.1) | 25.9 (17.5–51.8) | 0.3 |
| Median days since last drink before admission (IQR) | 5 (1–26) | 7 (2–21) | 4.5 (1–24) | 0.43 |
| Median admission MELD (range) | 36 (20–40) | 31 (17–40) | 29 (19–40) | <0.001 |
| Median days between last drink and OLT eval (IQR) | 24 (15–43) | 23 (14–47) | 14 (6–32) | 0.068 |
| Median MELD at eval (range) | 38 (25–40) | 34 (25–40) | 29 (22–40) | <0.001 |
| Median drinks/day (range) | 12 (4–40) | 12 (2–60) | 8 (3–23) | 0.16 |
| Median years drinking (range) | 15 (1–40) | 20 (3–42) | 18 (1–39) | 0.11 |
| NIAAA criteria | ||||
| Definite | 8 (16.3%) | 11 (18.0%) | 6 (17.6%) | 0.38 |
| Probable | 29 (59.2%) | 31 (50.8%) | 25 (73.5%) | |
| Possible | 12 (24.5%) | 19 (31.1%) | 3 (8.8%) | |
| Corticosteroids for AH | 35/49 (71.4%) | 31/61 (50%) | 14/35 (40%) | 0.02 |
| If not, why | ||||
| Infection | 9 (60%) | 11 (35.5%) | 9 (52.9%) | |
| GI bleeding | 4 (26.7%) | 4 (12.9%) | 3 (17.6%) | |
| Unknown | 1 (6.7%) | 16 (51.6%) | 5 (29.4%) | |
| Median Lille score (range) | 0.75 (0.11–1.00) | 0.82 (0.47–0.99) | 0.74 (0.32–0.94) | 0.7 |
| HE | ||||
| Severe | 12 (24.5%) | 13 (21.3%) | 0 (0.0%) | |
| Moderate | 25 (51.0%) | 32 (52.5%) | 17 (50.0%) | 0.04 |
| Mild | 7 (14.3%) | 9 (14.8%) | 9 (26.5%) | |
| None | 5 (10.2%) | 7 (11.5%) | 8 (23.5%) | |
| Median peak MELD (range) | 40 (28–40) | 39 (26–40) | 30.5 (25–45) | <0.001 |
| Approved for transplant | 49/49 (100%) | 1/61 (1.6%) | 4/34 (11.8%) | |
| Stated reason for not transplanting | ||||
| Psychosocial | 32 (52.4%) | 15 (50.0%) | ||
| Medical | 1 (1.6%) | 2 (6.7%) | ||
| Recovery | 0 (0.0%) | 12 (40.0%) | ||
| Insurance | 2 (3.2%) | 0 (0.0%) | ||
| Patient choice | 1 (1.6%) | 1 (3.3%) | ||
| Patient died | 21 (34.4%) | 0 (0.0%) | ||
| Median MELD at LT | 40 | NA | NA | |
| Median days between eval and LT | 14 | NA | NA | |
| Peak MELD | ||||
| 40+ | 34/49 | 27/61 | 4/34 | <0.001 |
| 36–39 | 6/49 | 11/61 | 3/34 | |
| 33–35 | 6/49 | 11/61 | 5/34 | |
| 30–32 | 1/49 | 5/61 | 8/34 | |
| 29 or less | 1/49 | 7/61 | 14/34 | |
| Median DF at admission (range) | 92 (26–372) | 85.3 (25–500) | 70 (26–221) | 0.04 |
| Median days of follow–up from eval (IQR) | 1015 (755–2096) | 22 (10–41) | 795 (523–1287) | <0.001 |
| Alcohol use in follow–up period | 21/49 (42.9%) | NA | 13/34 (38.2%) | 0.17 |
| Cause of death | Liver failure 3 | Liver failure 57 | Liver failure 6 | |
| Perioperative 4 | Sepsis 1 | |||
| Sepsis 1 | ICH 1 | |||
| AAA rupture 1 | ||||
| Unknown 4 | ||||
- Abbreviations: AAA, abdominal aortic aneurysm; BMI, body mass index; eval, evaluation; GI, gastrointestinal; ICH, intracerebral hemorrhage; NA, not applicable; OLT, orthotopic liver transplantation.
We apologize for this error.
中文翻译：
勘误表
在 Musto, et al., [ 1 ]的表 1 中，PEAK Meld 下列出的行中的数值被错误地格式化为日期。此处显示了更正后的表 1。
| 多变的 | 移植 | 不移植不康复 | 恢复 | p值 |
|---|---|---|---|---|
| 平均年龄 (SD) | 44.2 (11.5) | 50.0 (9.8) | 43.6 (10.8) | 0.004 |
| 男性 | 32/49 (65.3%) | 47/61 (77.0%) | 19/34 (55.9%) | 0.09 |
| BMI 中位数（范围） | 31.1 (22.7–53.5) | 30.5 (18.5–77.1) | 25.9 (17.5–51.8) | 0.3 |
| 自入院前最后一次饮酒以来的中位天数 (IQR) | 5 (1–26) | 7 (2–21) | 4.5 (1–24) | 0.43 |
| 平均入学 MELD（范围） | 36 (20–40) | 31 (17–40) | 29 (19–40) | <0.001 |
| 最后一次饮酒和 OLT eval (IQR) 之间的中位天数 | 24 (15–43) | 23 (14–47) | 14 (6–32) | 0.068 |
| 评估时的 MELD 中值（范围） | 38 (25–40) | 34 (25–40) | 29 (22–40) | <0.001 |
| 中位数饮料/天（范围） | 12 (4–40) | 12 (2–60) | 8 (3–23) | 0.16 |
| 平均饮酒年数（范围） | 15 (1–40) | 20 (3–42) | 18 (1–39) | 0.11 |
| NIAAA 标准 | ||||
| 定 | 8 (16.3%) | 11 (18.0%) | 6 (17.6%) | 0.38 |
| 可能 | 29 (59.2%) | 31 (50.8%) | 25 (73.5%) | |
| 可能的 | 12 (24.5%) | 19 (31.1%) | 3 (8.8%) | |
| 用于 AH 的皮质类固醇 | 35/49 (71.4%) | 31/61 (50%) | 14/35 (40%) | 0.02 |
| 如果不是，为什么 | ||||
| 感染 | 9 (60%) | 11 (35.5%) | 9 (52.9%) | |
| 胃肠道出血 | 4 (26.7%) | 4 (12.9%) | 3 (17.6%) | |
| 未知 | 1 (6.7%) | 16 (51.6%) | 5 (29.4%) | |
| 中值里尔得分（范围） | 0.75 (0.11–1.00) | 0.82 (0.47–0.99) | 0.74 (0.32–0.94) | 0.7 |
| 他 | ||||
| 严重的 | 12 (24.5%) | 13 (21.3%) | 0 (0.0%) | |
| 缓和 | 25 (51.0%) | 32 (52.5%) | 17 (50.0%) | 0.04 |
| 温和的 | 7 (14.3%) | 9 (14.8%) | 9 (26.5%) | |
| 没有任何 | 5 (10.2%) | 7 (11.5%) | 8 (23.5%) | |
| 中值峰值 MELD（范围） | 40 (28–40) | 39 (26–40) | 30.5 (25–45) | <0.001 |
| 获准移植 | 49/49 (100%) | 1/61 (1.6%) | 4/34 (11.8%) | |
| 说明不移植的原因 | ||||
| 社会心理 | 32 (52.4%) | 15 (50.0%) | ||
| 医疗的 | 1 (1.6%) | 2 (6.7%) | ||
| 恢复 | 0 (0.0%) | 12 (40.0%) | ||
| 保险 | 2 (3.2%) | 0 (0.0%) | ||
| 患者选择 | 1 (1.6%) | 1 (3.3%) | ||
| 患者死亡 | 21 (34.4%) | 0 (0.0%) | ||
| LT 的 MELD 中值 | 40 | 不适用 | 不适用 | |
| eval 和 LT 之间的中位数天数 | 14 | 不适用 | 不适用 | |
| 峰值融合 | ||||
| 40+ | 34/49 | 27/61 | 4/34 | <0.001 |
| 36–39 | 6/49 | 11/61 | 3/34 | |
| 33–35 | 6/49 | 11/61 | 5/34 | |
| 30–32 | 1/49 | 5/61 | 8/34 | |
| 29 或更少 | 1/49 | 7/61 | 14/34 | |
| 入院时的中位 DF（范围） | 92 (26–372) | 85.3 (25–500) | 70 (26–221) | 0.04 |
| eval 的中位随访天数 (IQR) | 1015 (755–2096) | 22 (10–41) | 795 (523–1287) | <0.001 |
| 随访期间饮酒 | 21/49 (42.9%) | 不适用 | 13/34 (38.2%) | 0.17 |
| 死亡原因 | 肝衰竭 3 | 肝功能衰竭 57 | 肝功能衰竭 6 | |
| 围手术期 4 | 败血症 1 | |||
| 败血症 1 | 非物质文化遗产 1 | |||
| AAA 破裂 1 | ||||
| 未知 4 | ||||
- 缩写：AAA，腹主动脉瘤；BMI，体重指数；评价，评价；GI，胃肠道；ICH，脑出血; NA，不适用；OLT，原位肝移植。
对于这个错误，我们深表歉意。
京公网安备 11010802027423号